An interventional study of Cerclage fixation and Tension band wiring in Olecranon Fracture, sponsored by Region Skane. Recruiting at 2 sites in Sweden. Open to participants aged 18 Years and older. Per ClinicalTrials.gov, last updated 2026-09-01.
Sponsored by Region Skane · Not applicable, Interventional, and Treatment
Fractures of the elbow tip (olecranon) that leave the elbow joint stable but where the fracture ends are separated (Mayo type 2a and 2b) can be treated with pins and a metal wire (tension band wiring, TBW) or metal wiring alone (cerclage fixation, CF ). Previous studies have reported high re-operation and complication rates following TBW. The current study's hypothesis, based on two retrospective studies, is that CF of these fractures yield lower re-operation rates compared with TBW. The investigators also hypothesize that the overall complication rate will be lower following CF. The aim is to investigate this hypothesis in a randomized controlled trial. Patients that are 18 years or older with Mayo type 2a and 2b olecranon fractures at Skåne University hospital will be invited to the study. Participation is voluntary. Patients who accept participation will be randomly assigned to surgery by either TBW or cerclage fixation. Two hundred participants will be followed by physiotherapists for 36 months post-surgery assessing re-operations, complications, patient reported outcome, and elbow function.
The complete study protocol including a detailed description of the trial will be published in a journal before the start of the trial.
Olecranon fractures account for approximately 20% of all proximal fractures of the forearm. Stable, undisplaced fractures (Mayo type 1a and 1b) are routinely treated non-operatively, while displaced and unstable fractures (Mayo type 3a and 3b) are typically operated with plate fixation. Stable, displaced fractures (Mayo type 2a and 2b) are often treated with tension band wiring (TBW) or plate fixation. TBW is associated with soft tissue irritation and high re-operation rates with hardware removal, ranging from 25% to 84% in the literature. Plate fixation was associated with fewer re-operations compared with TBW in a randomized controlled trial, but complications following plate fixation were more severe. A Cochrane review from 2014 did not find any significant support favouring either of the two methods. Non-operative treatment of Mayo type 2a and 2b fractures can yield acceptable results in elderly patients, but is not routinely used in younger individuals with higher functional demands. Two previous retrospective studies from 2002 and 2021 reported that Mayo 2a and 2b fractures can be operated with cerclage fixation alone yielding half the re-operation rates when compared to TBW. As of April 2022 there are two studies (one active (NCT03280602) and one completed (NCT01391936)) comparing TBW vs plate fixation, three studies (two active (NCT04670900 and NCT04401462) and one terminated (NCT01397643)) comparing non-operative vs operative treatment in elderly and one active study (NCT04189185) comparing TBW vs suture fixation registered on this site. The hypothesis of the current study is that the re-operation rate and the complication rate will be lower following CF compared with TBW while yielding equal results in other outcome measures. The aim is to to investigate this in a prospective randomized clinical trial.
Methodology:
All patients presenting at Skåne University Hospital in Malmö and Lund, Sweden, with olecranon fractures of Mayo type 2a and 2b will be invited to participate in the study if they do not meet any exclusion criteria. Potential subjects will be asked to sign a consent form after receiving written and oral information about the trial. Subjects will be randomized 1:1 to surgery with TBW or cerclage. 200 subjects will be recruited based on sample size calculations derived from the re-operation frequency in a previous study (PMID: 34236459)
Baseline descriptive data will be collected at inclusion or in the peri-operative period. Operation time, intra-operative effective radiation dose and radiation time will be recorded. Subjects will be invited to follow-up to a physiotherapist at 2 weeks, 6 weeks, 3 months, 12 months and 36 months after the operation assessing re-operations, complications, post-operative antibiotics, range of elbow motion, grip strength, the Quick Disabilities of the Arm, Shoulder and Hand score (Quick-DASH, references PMID: 8773720 and 6709254), overall patient satisfaction, pain, return to work and secondary dislocation. The Short Musculoskeletal Function Assessment (SMFA, references PMID: 27994082 and 14763711) score will be assessed 12 months post-operatively. The physiotherapist will be masked to the treatment method. At 6 months one radiograph will be collected for assessment of non-union.
The primary outcome measure will be re-operations. Secondary outcome measures will be patient reported outcome measures and complications. Tertiary outcome measures are post-operative range of motion and grip strength, secondary dislocation rate, time to return to work after surgery, operation time, effective intra-operative radiation dose and radiation time. The hypothesis of the current study is that cerclage fixation will yield less re-operations, less overall complications and less severe complications while other outcome measures will be equal.
21 studies on the registry are indexed under Elbow Injuries; 6 are open to participants now.
This study's planned enrollment of 200 is above the median of 52 across 13 interventional studies indexed under Elbow Injuries.
Browse Elbow Injuries studies →Region Skane is the lead sponsor of 386 studies on the registry; 122 are open to participants now.
Counted across the registry records on this site, refreshed daily.
Go through the criteria one by one — yes, no or not sure — and take the list to your doctor or the study team. Kept in this browser only.
Exclusion Criteria:
Underlined terms in the criteria open these too. Explained by clinicaltrials.gg, not part of the registry record. The study team decides who can take part.
Cancer that has spread from where it began to other parts of the body. “Metastatic” cancer is cancer that has spread this way.
Metastases
Cancer that has spread from where it began to other parts of the body. “Metastatic” cancer is cancer that has spread this way.
Explained by clinicaltrials.gg, not part of the registry record. The study team decides who can take part.
Intervention by cerclage fixation.
Procedure: Cerclage fixation
Intervention by tension band wiring
Procedure: Tension band wiring
The intervention is by surgical open reduction and internal fixation of the fracture using two 1.0mm cerclage.
The intervention is by surgical open reduction and internal fixation of the fracture using a 1.0mm cerclage and two 1.6 mm k-wires as described in AO-guidelines.
Re-operation rate 1.5 months.
Total re-operation rate of the operated elbow regardless of cause.
Time frame: Recorded at 1.5 months after intervention.
Re-operation rate 3 months.
Total re-operation rate of the operated elbow regardless of cause.
Time frame: Recorded at 3 months after intervention.
Re-operation rate 12 months.
Total re-operation rate of the operated elbow regardless of cause.
Time frame: Recorded at 12 months after intervention.
Re-operation rate 36 months.
Total re-operation rate of the operated elbow regardless of cause.
Time frame: Recorded at 36 months after intervention.
Complication rate 1.5 months.
Total complication rate.
Time frame: Recorded at 1.5 months after intervention.
Complication rate 3 months.
Total complication rate.
Time frame: Recorded at 3 months after intervention.
Complication rate 12 months.
Total complication rate.
Time frame: Recorded at 12 months after intervention.
Complication rate 36 months.
Total complication rate.
Time frame: Recorded at 36 months after intervention.
Complication severity 1.5 months.
Complication severity classified with the Clavien-Dindo Classification.
Time frame: Recorded at 1.5 months after intervention.
Complication severity 3 months.
Complication severity classified with the Clavien-Dindo Classification.
Time frame: Recorded at 3 months after intervention.
Complication severity 12 months.
Complication severity classified with the Clavien-Dindo Classification.
Time frame: Recorded at 12 months after intervention.
Complication severity 36 months.
Complication severity classified with the Clavien-Dindo Classification.
Time frame: Recorded at 36 months after intervention.
Quick-DASH 1.5 months.
Quick-DASH questionnaire assessed by subjects. See references PMID: 8773720 and 6709254.
Time frame: 1.5 months after intervention.
Quick-DASH 3 months.
Quick-DASH questionnaire assessed by subjects. See references PMID: 8773720 and 6709254.
Time frame: 3 months after intervention.
Quick-DASH 12 months.
Quick-DASH questionnaire assessed by subjects. See references PMID: 8773720 and 6709254.
Time frame: 12 months after intervention.
Quick-DASH 36 months.
Quick-DASH questionnaire assessed by subjects. See references PMID: 8773720 and 6709254.
Time frame: 36 months after intervention.
SMFA 12 months
SMFA-questionnaire assessed by subjects. See reference PMID: 27994082 and 14763711
Time frame: 12 months after intervention.
Pain level 1.5 months.
Subjective pain level in motion and at rest. Measured with a visual analog scale.
Time frame: Recorded at 1.5 months after intervention
Pain level 3 months.
Subjective pain level in motion and at rest. Measured with a visual analog scale.
Time frame: Recorded at 3 months after intervention.
Pain level 12 months,
Subjective pain level in motion and at rest. Measured with a visual analog scale.
Time frame: Recorded at 12 months after intervention.
Pain level 36 months.
Subjective pain level in motion and at rest. Measured with a visual analog scale.
Time frame: Recorded at 36 months after intervention.
Overall satisfaction 1.5 months.
Subjective overall satisfaction level. Measured with a visual analog scale.
Time frame: Recorded at 1.5 months after intervention.
Overall satisfaction 3 months.
Subjective overall satisfaction level. Measured with a visual analog scale.
Time frame: Recorded at 3 months after intervention.
Overall satisfaction 12 months.
Subjective overall satisfaction level. Measured with a visual analog scale.
Time frame: Recorded at 12 months after intervention.
Overall satisfaction 36 months.
Subjective overall satisfaction level. Measured with a visual analog scale.
Time frame: Recorded at 36 months after intervention.
Grip strength 0.5 months.
Grips strength will be evaluated using a JAMAR dynamometer as detailed in the Swedish National Quality Register for Hand Surgery (HAKIR)
Time frame: Recorded at 0.5 months after intervention.
Grip strength 1.5 months.
Grips strength will be evaluated using a JAMAR dynamometer as detailed in the Swedish National Quality Register for Hand Surgery (HAKIR)
Time frame: Recorded at 1.5 months after intervention.
Grip strength 3 months.
Grips strength will be evaluated using a JAMAR dynamometer as detailed in the Swedish National Quality Register for Hand Surgery (HAKIR)
Time frame: Recorded at 3 months after intervention.
Grip strength 12 months.
Grips strength will be evaluated using a JAMAR dynamometer as detailed in the Swedish National Quality Register for Hand Surgery (HAKIR)
Time frame: Recorded at 12 months after intervention.
Grip strength 36 months.
Grips strength will be evaluated using a JAMAR dynamometer as detailed in the Swedish National Quality Register for Hand Surgery (HAKIR)
Time frame: Recorded at 36 months after intervention.
Range of motion 0.5 months.
Active extension, flexion, pronation and supination will be evaluated using a goniometer following the Swedish National Quality Register for Hand Surgery (HAKIR) guidelines.
Time frame: Recorded at 0.5 months after intervention.
Range of motion 1.5 months.
Active extension, flexion, pronation and supination will be evaluated using a goniometer following the Swedish National Quality Register for Hand Surgery (HAKIR) guidelines.
Time frame: Recorded at 1.5 months after intervention.
Range of motion 3 months.
Active extension, flexion, pronation and supination will be evaluated using a goniometer following the Swedish National Quality Register for Hand Surgery (HAKIR) guidelines.
Time frame: Recorded at 3 months after intervention.
Range of motion 12 months.
Active extension, flexion, pronation and supination will be evaluated using a goniometer following the Swedish National Quality Register for Hand Surgery (HAKIR) guidelines.
Time frame: Recorded at 12 months after intervention.
Range of motion 36 months.
Active extension, flexion, pronation and supination will be evaluated using a goniometer following the Swedish National Quality Register for Hand Surgery (HAKIR) guidelines.
Time frame: Recorded at 36 months after intervention.
Time to return to work 1.5 months.
Time to return to work in days will be evaluated for all working subjects.
Time frame: Recorded at 1.5 months after intervention.
Time to return to work 3 months.
Time to return to work in days will be evaluated for all working subjects.
Time frame: Recorded at 3 months after intervention.
Time to return to work 12 months.
Time to return to work in days will be evaluated for all working subjects.
Time frame: Recorded at 12 months after intervention.
Time to return to work 36 months.
Time to return to work in days will be evaluated for all working subjects.
Time frame: Recorded at 36 months after intervention.
Secondary dislocation rate.
Secondary dislocation rate will be assessed with a one lateral view radiograph of the operated elbow.
Time frame: 6 months after intervention.
Intra-operative fluoroscopy radiation level.
Intra-operative fluoroscopy radiation DAP will be recorded at the time of surgery from the fluoroscopy machine used.
Time frame: Peri-operative.
Intra-operative fluoroscopy time.
Intra-operative fluoroscopy time will be recorded at the time of surgery from the fluoroscopy machine used.
Time frame: Peri-operative.
Antibiotic treatment 1.5.
Any unplanned prescription of antibiotics after the intervention related to the injury.
Time frame: Recorded at 1.5 months after intervention.
Antibiotic treatment 3.
Any unplanned prescription of antibiotics after the intervention related to the injury.
Time frame: Recorded at 3 months after intervention.
Antibiotic treatment 12.
Any unplanned prescription of antibiotics after the intervention related to the injury.
Time frame: Recorded at 12 months after intervention.
Antibiotic treatment 36.
Any unplanned prescription of antibiotics after the intervention related to the injury.
Time frame: Recorded at 36 months after intervention.
Surgical time.
Time from incision to completed wound closure will be recorded during surgery.
Time frame: Peri-operative.
Plan to share: No
Eligibility is decided by the study team. Share this record with your doctor or contact the team directly.
Contact study teamGet an email when the registry record changes — status, dates, results — or when someone posts here.
Sign in to followQuestions and observations about this study, from anyone following it. Not medical advice, and not a channel to the study team — their contact details are on the registry record.
Sign in to join the discussion. Reading takes no account; posting does. You choose a display name, and a pseudonym is the default.
Nothing here yet. If you are running this trial, taking part in it, or weighing whether to, this is the place to say so.